TP53 and acute myeloid leukemia: The results of pairwise interactions showed that the effect of the TP53 rs1042522 variant was modified by MDM2 rs2279744, and patients with combined variant homozygous genotypes for MDM2 rs2279744 and TP53 rs1042522 have increased odds of AML.